These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9384849)

  • 1. Neurobiologic basis of anxiety and its treatment.
    Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
    Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on the mode of action of benzodiazepines.
    Leonard BE
    J Psychiatr Res; 1993; 27 Suppl 1():193-207. PubMed ID: 7908333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GABAA/benzodiazepine receptor: implications for the molecular basis of anxiety.
    Breier A; Paul SM
    J Psychiatr Res; 1990; 24 Suppl 2():91-104. PubMed ID: 1980704
    [No Abstract]   [Full Text] [Related]  

  • 4. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The benzodiazepine receptor: the enigma of the endogenous ligand].
    Pélissolo A
    Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disorders and anxiety: biochemical antecedents and pharmacological consequences.
    Leonard BE
    J Psychosom Res; 1994; 38 Suppl 1():69-87. PubMed ID: 7799254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current hypotheses of the central mechanism of action of benzodiazepine tranquilizers].
    Bouchard LP; Llorca PM; Wolf MA
    Can J Psychiatry; 1991 Nov; 36(9):660-6. PubMed ID: 1685351
    [No Abstract]   [Full Text] [Related]  

  • 10. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems.
    Suranyi-Cadotte BE; Bodnoff SR; Welner SA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):633-54. PubMed ID: 1705717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives].
    Kostowski W; Płaźnik A
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H
    Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gamma-aminobutyric acid in anxiety.
    Enna SJ
    Psychopathology; 1984; 17 Suppl 1():15-24. PubMed ID: 6143341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics: a hypothetical allosteric model of the benzodiazepine receptor complex.
    Williams M
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):209-47. PubMed ID: 6146163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines: selective administration.
    Ananth J
    J Affect Disord; 1987; 13(2):99-108. PubMed ID: 2890681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitters in anxiety.
    Hoehn-Saric R
    Arch Gen Psychiatry; 1982 Jun; 39(6):735-42. PubMed ID: 6124225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
    Rupprecht R
    Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.